Clinical Trial Update: Osseous Setting Improvement With Co-implantation of Osseous Matrix and Mesenchymal Progenitors Cells From Autologous Bone Marrow [Phase 2]

View source ↗

Summary

Phase 2 study evaluating co-implantation of Osseous Matrix with autologous mesenchymal progenitor cells for tibia or femur nonunion. The trial status is suspend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femur Nonunion
• Tibia Nonunion

Drugs mentioned

• Autologous bone marrow-derived mesenchymal progenitor cells (Mesenchymal progenitor cells)
• Osseous Matrix (Osseous Matrix)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Tibia or Femur Pseudo-arthrosis | Phase 2 | Status: SUSPENDED